Skip to content
10-Q

Quarterly Report

FORMA THERAPEUTICS HOLDINGS, INC.

0000950170-22-008130

← back to feed
Filed
May 6, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 28, 2022 47.8M sh
Capex Q1 2022 · Mar 31, 2022 $261K
Capex Q1 2022 · Mar 31, 2021 $83K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$49.3M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$41.24M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $74.42M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $77.42M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $97.83M
Stockholders Equity Q1 2022 · Mar 31, 2022 $461.19M
Stockholders Equity Q1 2022 · Dec 31, 2021 $498.36M
Stockholders Equity Q1 2022 · Mar 31, 2021 $616.47M
Stockholders Equity Q1 2022 · Dec 31, 2020 $648.24M
Current Liabilities Q1 2022 · Mar 31, 2022 $26.34M
Current Liabilities Q1 2022 · Dec 31, 2021 $35.09M
Total Liabilities Q1 2022 · Mar 31, 2022 $53.3M
Total Liabilities Q1 2022 · Dec 31, 2021 $62.71M
Current Assets Q1 2022 · Mar 31, 2022 $446.53M
Current Assets Q1 2022 · Dec 31, 2021 $486.4M
Total Assets Q1 2022 · Mar 31, 2022 $514.5M
Total Assets Q1 2022 · Dec 31, 2021 $561.06M
Sga Expense Q1 2022 · Mar 31, 2022 $13.14M
Sga Expense Q1 2022 · Mar 31, 2021 $9.87M
Rd Expense Q1 2022 · Mar 31, 2022 $31.27M
Rd Expense Q1 2022 · Mar 31, 2021 $26.34M
Net Income Q1 2022 · Mar 31, 2022 −$44.16M
Net Income Q1 2022 · Mar 31, 2021 −$35.96M
Operating Income Q1 2022 · Mar 31, 2022 −$44.41M
Operating Income Q1 2022 · Mar 31, 2021 −$36.21M
Revenue Q1 2022 · Mar 31, 2022 $0
Revenue Q1 2022 · Mar 31, 2021 $0